bluuebunny/crossref_metadata_2025_split huggingface dataset:
Bone and Soft Tissue Tumours
Authors: Sobin L. H. , Gospodarowicz M.K. , Wittekind Ch. 
Published: September 2012

Abstract
There are no changes in the bone and soft tissue tumours classification in TNM‐7. Gastrointestinal stromal tumours (GIST) are newly classified in TNM‐7 (in the Digestive System chapter). The classification is based on GIST's three major prognostic factors: site, size, and mitotic rate. The categorization is the result of studies of over two thousand cases by Miettinen et al.
Bone
Authors: Sobin L. H. , Gospodarowicz M.K. , Wittekind Ch. 
Published: September 2012

Abstract

The TNM system is used to describe and classify cancer stages and progression based on the assessment of three components:

T

The extent of the primary tumour

N

The absence or presence and extent of regional lymph node metastasis

M

The absence or presence of distant metastasis.

TNM classification for the above site is described under the following headings:

Rules for classification with the procedures for assessing T, N, and M categories; additional methods may be used when they enhance the accuracy of appraisal before treatment

Anatomical sites and subsites where appropriate

Definition of the regional lymph nodes

TNM Clinical classification

pTNM Pathological classification

G Histopathological grading

Stage grouping

Summary
Skin Tumours
Authors: Sobin L. H. , Gospodarowicz M.K. , Wittekind Ch. 
Published: September 2012

Abstract
For skin carcinoma there are changes in T categories and in the regional lymph node classification. Several high risk features are enumerated that could have prognostic relevance. A new classification for Merkel cell carcinoma has been introduced, which has some features of the carcinoma and some of the melanoma classifications. The skin melanoma classification remains unchanged from TNM 6.
Carcinoma of Skin
Authors: Sobin L. H. , Gospodarowicz M.K. , Wittekind Ch. 
Published: September 2012

Abstract

The TNM system is used to describe and classify cancer stages and progression based on the assessment of three components:

T

The extent of the primary tumour

N

The absence or presence and extent of regional lymph node metastasis

M

The absence or presence of distant metastasis.

TNM classification for the above site is described under the following headings:

Rules for classification with the procedures for assessing T, N, and M categories; additional methods may be used when they enhance the accuracy of appraisal before treatment

Anatomical sites and subsites where appropriate

Definition of the regional lymph nodes

TNM Clinical classification

pTNM Pathological classification

G Histopathological grading

Stage grouping

Summary
Malignant Melanoma of Skin
Authors: Sobin L. H. , Gospodarowicz M.K. , Wittekind Ch. 
Published: September 2012

Abstract

The TNM system is used to describe and classify cancer stages and progression based on the assessment of three components:

T

The extent of the primary tumour

N

The absence or presence and extent of regional lymph node metastasis

M

The absence or presence of distant metastasis.

TNM classification for the above site is described under the following headings:

Rules for classification with the procedures for assessing T, N, and M categories; additional methods may be used when they enhance the accuracy of appraisal before treatment

Anatomical sites and subsites where appropriate

Definition of the regional lymph nodes

TNM Clinical classification

pTNM Pathological classification

G Histopathological grading

Stage grouping

Summary
Gynaecological Tumours
Authors: Sobin L. H. , Gospodarowicz M.K. , Wittekind Ch. 
Published: September 2012

Abstract
T and N categories of vulva have changed in TNM‐7. A major addition is the introduction of classifications for uterine sarcomas: adenosarcoma, leiomyosarcoma, and endometrial stromal sarcoma. These changes are all done in close collaboration with the International Federation of Gynecologists and Obstetricians (FIGO).
Vulva
Authors: Sobin L. H. , Gospodarowicz M.K. , Wittekind Ch. 
Published: September 2012

Abstract

The TNM system is used to describe and classify cancer stages and progression based on the assessment of three components:

T

The extent of the primary tumour

N

The absence or presence and extent of regional lymph node metastasis

M

The absence or presence of distant metastasis.

TNM classification for the above site is described under the following headings:

Rules for classification with the procedures for assessing T, N, and M categories; additional methods may be used when they enhance the accuracy of appraisal before treatment

Anatomical sites and subsites where appropriate

Definition of the regional lymph nodes

TNM Clinical classification

pTNM Pathological classification

G Histopathological grading

Stage grouping

Summary
Vagina
Authors: Sobin L. H. , Gospodarowicz M.K. , Wittekind Ch. 
Published: September 2012

Abstract

The TNM system is used to describe and classify cancer stages and progression based on the assessment of three components:

T

The extent of the primary tumour

N

The absence or presence and extent of regional lymph node metastasis

M

The absence or presence of distant metastasis.

TNM classification for the above site is described under the following headings:

Rules for classification with the procedures for assessing T, N, and M categories; additional methods may be used when they enhance the accuracy of appraisal before treatment

Anatomical sites and subsites where appropriate

Definition of the regional lymph nodes

TNM Clinical classification

pTNM Pathological classification

G Histopathological grading

Stage grouping

Summary
Uterus ‐ Endometrium
Authors: Sobin L. H. , Gospodarowicz M.K. , Wittekind Ch. 
Published: September 2012

Abstract

The TNM system is used to describe and classify cancer stages and progression based on the assessment of three components:

T

The extent of the primary tumour

N

The absence or presence and extent of regional lymph node metastasis

M

The absence or presence of distant metastasis.

TNM classification for the above site is described under the following headings:

Rules for classification with the procedures for assessing T, N, and M categories; additional methods may be used when they enhance the accuracy of appraisal before treatment

Anatomical sites and subsites where appropriate

Definition of the regional lymph nodes

TNM Clinical classification

pTNM Pathological classification

G Histopathological grading

Stage grouping

Summary
Ovary
Authors: Sobin L. H. , Gospodarowicz M.K. , Wittekind Ch. 
Published: September 2012

Abstract

The TNM system is used to describe and classify cancer stages and progression based on the assessment of three components:

T

The extent of the primary tumour

N

The absence or presence and extent of regional lymph node metastasis

M

The absence or presence of distant metastasis.

TNM classification for the above site is described under the following headings:

Rules for classification with the procedures for assessing T, N, and M categories; additional methods may be used when they enhance the accuracy of appraisal before treatment

Anatomical sites and subsites where appropriate

Definition of the regional lymph nodes

TNM Clinical classification

pTNM Pathological classification

G Histopathological grading

Stage grouping

Summary
Fallopian Tube
Authors: Sobin L. H. , Gospodarowicz M.K. , Wittekind Ch. 
Published: September 2012

Abstract

The TNM system is used to describe and classify cancer stages and progression based on the assessment of three components:

T

The extent of the primary tumour

N

The absence or presence and extent of regional lymph node metastasis

M

The absence or presence of distant metastasis.

TNM classification for the above site is described under the following headings:

Rules for classification with the procedures for assessing T, N, and M categories; additional methods may be used when they enhance the accuracy of appraisal before treatment

Anatomical sites and subsites where appropriate

Definition of the regional lymph nodes

TNM Clinical classification

pTNM Pathological classification

G Histopathological grading

Stage grouping

Summary
Gestational Trophoblastic Tumours
Authors: Sobin L. H. , Gospodarowicz M.K. , Wittekind Ch. 
Published: September 2012

Abstract

The TNM system is used to describe and classify cancer stages and progression based on the assessment of three components:

T

The extent of the primary tumour

N

The absence or presence and extent of regional lymph node metastasis

M

The absence or presence of distant metastasis.

TNM classification for the above site is described under the following headings:

Rules for classification with the procedures for assessing T, N, and M categories; additional methods may be used when they enhance the accuracy of appraisal before treatment

Anatomical sites and subsites where appropriate

Definition of the regional lymph nodes

TNM Clinical classification

pTNM Pathological classification

G Histopathological grading

Stage grouping

Summary
Penis
Authors: Sobin L. H. , Gospodarowicz M.K. , Wittekind Ch. 
Published: September 2012

Abstract

The TNM system is used to describe and classify cancer stages and progression based on the assessment of three components:

T

The extent of the primary tumour

N

The absence or presence and extent of regional lymph node metastasis

M

The absence or presence of distant metastasis.

TNM classification for the above site is described under the following headings:

Rules for classification with the procedures for assessing T, N, and M categories; additional methods may be used when they enhance the accuracy of appraisal before treatment

Anatomical sites and subsites where appropriate

Definition of the regional lymph nodes

TNM Clinical classification

pTNM Pathological classification

G Histopathological grading

Stage grouping

Summary
Prostate
Authors: Sobin L. H. , Gospodarowicz M.K. , Wittekind Ch. 
Published: September 2012

Abstract
The T, N, and M categories for prostate carcinoma remain unchanged from TNM 6. However, there is a dual (anatomic vs. prognostic) approach to the classification of prostate cancer with a purely TNM‐based stage grouping and a new prognostic grouping that combines TNM, PSA values, and Gleason score.
Kidney
Authors: Sobin L. H. , Gospodarowicz M.K. , Wittekind Ch. 
Published: September 2012

Abstract

The TNM system is used to describe and classify cancer stages and progression based on the assessment of three components:

T

The extent of the primary tumour

N

The absence or presence and extent of regional lymph node metastasis

M

The absence or presence of distant metastasis.

TNM classification for the above site is described under the following headings:

Rules for classification with the procedures for assessing T, N, and M categories; additional methods may be used when they enhance the accuracy of appraisal before treatment

Anatomical sites and subsites where appropriate

Definition of the regional lymph nodes

TNM Clinical classification

pTNM Pathological classification

G Histopathological grading

Stage grouping

Summary
Renal Pelvis and Ureter
Authors: Sobin L. H. , Gospodarowicz M.K. , Wittekind Ch. 
Published: September 2012

Abstract

The TNM system is used to describe and classify cancer stages and progression based on the assessment of three components:

T

The extent of the primary tumour

N

The absence or presence and extent of regional lymph node metastasis

M

The absence or presence of distant metastasis.

TNM classification for the above site is described under the following headings:

Rules for classification with the procedures for assessing T, N, and M categories; additional methods may be used when they enhance the accuracy of appraisal before treatment

Anatomical sites and subsites where appropriate

Definition of the regional lymph nodes

TNM Clinical classification

pTNM Pathological classification

G Histopathological grading

Stage grouping

Summary
Urinary Bladder
Authors: Sobin L. H. , Gospodarowicz M.K. , Wittekind Ch. 
Published: September 2012

Abstract

The TNM system is used to describe and classify cancer stages and progression based on the assessment of three components:

T

The extent of the primary tumour

N

The absence or presence and extent of regional lymph node metastasis

M

The absence or presence of distant metastasis.

TNM classification for the above site is described under the following headings:

Rules for classification with the procedures for assessing T, N, and M categories; additional methods may be used when they enhance the accuracy of appraisal before treatment

Anatomical sites and subsites where appropriate

Definition of the regional lymph nodes

TNM Clinical classification

pTNM Pathological classification

G Histopathological grading

Stage grouping

Summary
Carcinoma of Skin of Eyelid
Authors: Sobin L. H. , Gospodarowicz M.K. , Wittekind Ch. 
Published: September 2012

Abstract

The TNM system is used to describe and classify cancer stages and progression based on the assessment of three components:

T

The extent of the primary tumour

N

The absence or presence and extent of regional lymph node metastasis

M

The absence or presence of distant metastasis.

TNM classification for the above site is described under the following headings:

Rules for classification with the procedures for assessing T, N, and M categories; additional methods may be used when they enhance the accuracy of appraisal before treatment

Anatomical sites and subsites where appropriate

Definition of the regional lymph nodes

TNM Clinical classification

pTNM Pathological classification

G Histopathological grading

Stage grouping

Summary
Sarcoma of Orbit
Authors: Sobin L. H. , Gospodarowicz M.K. , Wittekind Ch. 
Published: September 2012

Abstract

The TNM system is used to describe and classify cancer stages and progression based on the assessment of three components:

T

The extent of the primary tumour

N

The absence or presence and extent of regional lymph node metastasis

M

The absence or presence of distant metastasis.

TNM classification for the above site is described under the following headings:

Rules for classification with the procedures for assessing T, N, and M categories; additional methods may be used when they enhance the accuracy of appraisal before treatment

Anatomical sites and subsites where appropriate

Definition of the regional lymph nodes

TNM Clinical classification

pTNM Pathological classification

G Histopathological grading

Stage grouping

Summary
Carcinoma of Lacrimal Gland
Authors: Sobin L. H. , Gospodarowicz M.K. , Wittekind Ch. 
Published: September 2012

Abstract

The TNM system is used to describe and classify cancer stages and progression based on the assessment of three components:

T

The extent of the primary tumour

N

The absence or presence and extent of regional lymph node metastasis

M

The absence or presence of distant metastasis.

TNM classification for the above site is described under the following headings:

Rules for classification with the procedures for assessing T, N, and M categories; additional methods may be used when they enhance the accuracy of appraisal before treatment

Anatomical sites and subsites where appropriate

Definition of the regional lymph nodes

TNM Clinical classification

pTNM Pathological classification

G Histopathological grading

Stage grouping

Summary
Magnetic Hydrogels and Their Potential Biomedical Applications
Authors: Li Yuhui , Huang Guoyou , Zhang Xiaohui , Li Baoqiang , Chen Yongmei , Lu Tingli , Lu Tian Jian , Xu Feng 
Published: September 2012

AbstractHydrogels find widespread applications in biomedical engineering due to their hydrated environment and tunable properties (e.g., mechanical, chemical, biocompatible) similar to the native extracellular matrix (ECM). However, challenges still exist regarding utilizing hydrogels in applications such as engineering 3D tissue constructs and active targeting in drug delivery, due to the lack of controllability, actuation, and quick‐response properties. Recently, magnetic hydrogels have emerged as a novel biocomposite for their active response properties and extended applications. In this review, the state‐of‐the‐art methods for magnetic hydrogel preparation are presented and their advantages and drawbacks in applications are discussed. The applications of magnetic hydrogels in biomedical engineering are also reviewed, including tissue engineering, drug delivery and release, enzyme immobilization, cancer therapy, and soft actuators. Concluding remarks and perspectives for the future development of magnetic hydrogels are addressed.
Small‐Diameter Silk Vascular Grafts (3 mm Diameter) with a Double‐Raschel Knitted Silk Tube Coated with Silk Fibroin Sponge
Authors: Aytemiz Derya , Sakiyama Wataru , Suzuki Yu , Nakaizumi Naoki , Tanaka Ryou , Ogawa Yoko , Takagi Yoshihide , Nakazawa Yasumoto , Asakura Tetsuo 
Published: September 2012

AbstractSmall‐diameter (less than 6 mm in diameter) vascular grafts are highly desirable due to the large demand for surgical revascularization; however, there are no available artificial grafts. Vascular grafts of 1.5 mm diameter prepared by our group with silk fibroin fiber have been proved to be excellent grafts with remarkably high patency and remodeling, based on rat implantation experiment (Enomoto et al., 2010). In this study, a silk fibroin vascular graft with 3 mm diameter which can be used for the coronary arteries or lower extremity arteries is prepared with a double‐raschel knitted Bombyx mori silk fiber tube coated with B. mori silk fibroin sponge. Here the silk sponge is prepared from an aqueous solution of the silk fibroin and poly(ethylene) glycol diglycidyl ether as porogen. Sufficient strength, proper elasticity, and protection from loose ends in the implantation process are obtained for the silk fibroin graft; low water permeability and relatively large compliance are also attained. These excellent physical properties make silk fibroin grafts suitable to be implanted in a canine model.
Mild passive focal cooling prevents epileptic seizures after head injury in rats
Authors: D'Ambrosio Raimondo , Eastman Clifford L. , Darvas Felix , Fender Jason S. , Verley Derek R. , Farin Federico M. , Wilkerson Hui‐Wen , Temkin Nancy R. , Miller John W. , Ojemann Jeffrey , Rothman Steven M. , Smyth Matthew D. 
Published: September 2012

ObjectivePost‐traumatic epilepsy is prevalent, often difficult to manage, and currently cannot be prevented. Although cooling is broadly neuroprotective, cooling‐induced prevention of chronic spontaneous recurrent seizures has never been demonstrated. We examined the effect of mild passive focal cooling of the perilesional neocortex on the development of neocortical epileptic seizures after head injury in the rat.MethodsRostral parasagittal fluid percussion injury in rats reliably induces a perilesional, neocortical epileptic focus within weeks after injury. Epileptic seizures were assessed by 5‐electrode video‐electrocorticography (ECoG) 2 to 16 weeks postinjury. Focal cooling was induced with ECoG headsets engineered for calibrated passive heat dissipation. Pathophysiology was assessed by glial fibrillary acidic protein immunostaining, cortical sclerosis, gene expression of inflammatory cytokines interleukin (IL)‐1α and IL‐1β, and ECoG spectral analysis. All animals were formally randomized to treatment groups, and data were analyzed blind.ResultsCooling by 0.5 to 2°C inhibited the onset of epileptic seizures in a dose‐dependent fashion. The treatment induced no additional pathology or inflammation, and normalized the power spectrum of stage N2 sleep. Cooling by 2°C for 5.5 weeks beginning 3 days after injury virtually abolished ictal activity. This effect persisted through the end of the study, >10 weeks after cessation of cooling. Rare remaining seizures were shorter than in controls.InterpretationThese findings demonstrate potent and persistent prevention and modification of epileptic seizures after head injury with a cooling protocol that is neuroprotective, compatible with the care of head injury patients, and conveniently implemented. The required cooling can be delivered passively without Peltier cells or electrical power. ANN NEUROL 2013;73:199–209
Preparation and evaluation of aconitine imprinted microspheres and its application to body fluid samples
Authors: Yu Zerong , Su Qiaoling , Tang Youwen , Xu Zhiguang 
Published: September 2012

AbstractTo extract aconitine from body fluid samples, aconitine‐molecularly imprinted polymer microspheres with the optimum molar ratios of template/monomer/cross‐linker (1:8:40) as selective sorbents were synthesized by precipitation polymerization. Excellent retention of aconitine on the molecularly imprinted microspheres (MIMs) cartridge was achieved by optimizing the MISPE process, and the binding capacity reached 0.802mg/g, yielding an imprinting factor of 4.76. The MIMs also showed high selectivity for aconitum alkaloids, but not for other kinds of poisonous alkaloids. High recoveries (>89%) for aconitine, hypaconitine, and mesaconitine were got in spiked serum samples. The working curves show linear dependence on aconitine concentration in the range of 2.0–0.1 µg/mL, and the detection limits of aconitine, hypaconitine, and mesaconitine were 16.7, 18.3, 10.2 ng mL–1, respectively. © 2012 Wiley Periodicals, Inc. J. Appl. Polym. Sci., 2013
Thermal and dynamic mechanical characterization of acrylic bone cements modified with biodegradable polymers
Authors: Franco‐Marquès E. , Méndez J. A. , Gironès J. , Pèlach M. A. 
Published: September 2012

AbstractIn this work, a thermal and a dynamic mechanical study of new formulations self‐curing acrylic bone cements is reported. The basic formulation of poly(methylmethacrylate) (PMMA)‐based acrylic bone cements has been modified with biodegradable polyesters such as poly(l‐lactic acid), poly(β‐hydroxybutyrate), and different kinds of thermoplastic starches. Differential scanning calorimetry (DSC) (dynamic and isothermal conditions), thermogravimetric analysis (TGA), dynamic mechanical thermal analysis (DMTA), and scanning electron microscopy (SEM) were used to determine the influence of the biodegradable polymer in the behavior of the biomedical formulations. DSC assay revealed a strong dependence of the polymerization enthalpy (ΔHcur) with increasing solid : liquid ratio and a low influence of the nature of the added biodegradable polymer on glass transition. TGA analysis showed the different mechanism of PMMA‐biodegradable polymer interaction depending on the solubilization of the added polymer in methylmethacrylate monomer during curing. DMTA showed the reinforcing capacity of segregated phases of the polymer included in the cement. The solubilization of aliphatic polyesters in the resulting PMMA polymerized phase led to a drop in mechanical stiffness observed from storage modulus (E′) profiles. Moreover, tan δ shifts to higher temperatures (4–7°C) during a second scan, confirming the presence of residual monomer content. © 2012 Wiley Periodicals, Inc. J. Appl. Polym. Sci., 2013
Synthesis of syndiotactic poly(methacrylic acid) by free‐radical polymerization of the pseudo‐divinyl monomer formed with methacrylic acid and catechol
Authors: Saito Yoichi , Saito Reiko 
Published: September 2012

AbstractSyndiotactic poly(methacrylic acid) (Syn‐PMAA, r diad = 91 mol %) was synthesized by free radical polymerization of methacrylic acid (MAA) with catechol. The pseudo‐divinyl monomer was formed with one catechol and two MAA molecules by the hydrogen bonding between OH groups of catechol and COOH group of MAA. When the free radical polymerization of the pseudo‐divinyl monomer was carried out, intra‐ and intermolecular addition proceeded with racemic addition. The hydrogen bonding was the driving force to control tacticity. We discussed the effects of solvent, temperature, and the concentrations of MAA and catechol on the pseudo‐divinyl monomer formation. The highly syndiotactic PMAA was successfully obtained. © 2012 Wiley Periodicals, Inc. J. Appl. Polym. Sci., 2013